Kisspeptin and Pitavastatin Interaction

Synergistic
Mechanism-based 49% confidence

Kisspeptin and Pitavastatin have a synergistic interaction with 49% confidence. Pitavastatin helps manage estrogen conversion from Kisspeptin. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen. These compounds primarily affect different organ systems.

Compound Profiles

Kisspeptin

KISS1 Gene Product | Reproductive Neuropeptide

Binds to GPR54/KISS1R receptors on hypothalamic GnRH neurons, triggering pulsatile GnRH release, which stimulates pituitary LH/FSH secretion and gonadal steroid production..

Half-life: ~4 minutes (KP-10), ~28-32 minutes (KP-54) Typical dose: 100-200 mcg per injection sexual health, hormonal
estrogenic
View full profile

Pitavastatin

HMG-CoA Reductase Inhibitor | Low-Interaction Statin

Pitavastatin competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in the mevalonate pathway responsible for cholesterol biosynthesis in the liver. By blocking this enzyme, pitavastatin reduces intracellular cholesterol concentration in hepatocytes, triggering compensatory upregulation of LDL receptor expression on the hepatocyte surface.

Half-life: ~12 hours Typical dose: 1-4 mg/day cardiovascular
aromatase aromatase inhibitorhepatotoxiclipid disruptingteratogenic
View full profile

Combined Organ Load

Gonads
low
Heart
low

Frequently Asked Questions

Can I take Kisspeptin with Pitavastatin?

Yes, Kisspeptin and Pitavastatin can generally be taken together. Pitavastatin helps manage estrogen conversion from Kisspeptin. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen.

Is Kisspeptin and Pitavastatin safe together?

Based on pharmacological analysis, this combination is considered synergistic. No critical safety flags identified for this pair.

What are the interactions between Kisspeptin and Pitavastatin?

Pitavastatin helps manage estrogen conversion from Kisspeptin. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen. This assessment has 49% confidence and is inferred from pharmacological mechanism analysis.

How should I time Kisspeptin and Pitavastatin?

Kisspeptin has a half-life of ~4 minutes (KP-10), ~28-32 minutes (KP-54) and Pitavastatin has a half-life of ~12 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Kisspeptin vs Pitavastatin

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.